AMLODIPINE BESYLATE
NDC 70518-0835, AMLODIPINE BESYLATE, tablet, from REMEDYREPACK INC..
- Product NDC
- 70518-0835
- Status
- Listed
- Labeler
- REMEDYREPACK INC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077073
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70518-0835 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AMLODIPINE BESYLATE5 mg/1
Pharmacologic classes
Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A Inhibitors [MoA]; Dihydropyridine Calcium Channel Blocker [EPC]; Dihydropyridines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70518-0835-3 | 70518083503 | 30 TABLET in 1 BLISTER PACK (70518-0835-3) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d09173a1-5e3c-4c86-8c7c-15238925ef50
Use it
Look up 70518-0835 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70518-0835 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70518-0835. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.